EVENT / PUBLIC SOURCE RECORD
Norway: Catalysing novel partnerships for global impact
- Reception held 17 October 2025, 19:00–21:00 (GMT+01:00), at the Norwegian Ambassador’s Residence in Berlin during ESMO 2025. It brought together the Norwegian ESMO delegation, international oncology stakeholders, researchers, clinicians, industry leaders, and patient advocates. Registration is closed.
- The page describes Norway’s ambition to become a preferred country for clinical trials, health innovation, and industry collaboration, and notes that Norway and Germany formalised a bilateral health partnership in 2025. Topics included the national clinical-trials strategy; access to trial units and diagnostics; registries and biobanks; public-private collaboration; and NorTrials as an entry point. The evening included a fireside chat with oncology leaders and a networking dinner.
- Organisers: NorTrials, Oslo Cancer Cluster, HealthCatalyst, Royal Norwegian Embassy in Berlin, and Innovation Norway. Contacts: Signe Øien Fretland (sigfre@ous-hf.no), Jutta Heix (jh@oslocancercluster.no), and Martin Nietz (martin.nietz@innovationnorway.no). Related industry: health and life science.